参考文献/References:
［1］ BUI A L,HORWICH T B,FONAROW G C.Epidemiology and risk profile of heart failure［J］.Nat Rev Cardiol,2011,8(1):30-41.
［2］ COOK C,COLE G,ASARIA P,et al.The annual global economic burden of heart failure［J］.Int J Cardiol,2014,171(3):368-376.
［3］ HORTON J S,SHIRAISHI T,ALFULAIJ N,et al.TRPV1 is a com-ponent of the atrial natriuretic signaling complex,and using orally delivered antagonists,presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure［J］.Channels (Austin),2019,13(1):1-16.
［4］ GROSSMAN W,JONES D,MCLAURIN L P.Wall stress and patt-erns of hypertrophy in the human left ventricle［J］.J Clin Invest,1975,56(1):56-64.
［5］ ALFULAIJ N,MEINERS F,MICHALEK J,et al.Cannabinoids,the heart of the matter［J］.J Am Heart Assoc,2018,7(14):e009-e099.
［6］ FERREIRAL G B,FARIA R X.TRPing on the pore phenomenon:what do we know about transient receptor potential ion channel-related pore dilation up to now［J］.J Bioenerg Biomembr,2016,48(1):1-12.
［7］ SAMWAYS D S,TOMKIEWICZ E,LANGEVIN O M,et al.Meas-urement of relative Ca2+,permeability during sustained activation of TRPV1 receptors［J］.Pflügers Arch,2016,468(2):201-211.
［8］ ANDREI S R,SINHAROY P,BRATZ I N,et al.TRPA1 is fun-ctionally co-expressed with TRPV1 in cardiac muscle:co-localization at z-discs,costameres and intercalated discs［J］.Channels (Austin),2016,10(5):395-409.
［9］ ZHONG B,RUBINSTEIN J,MA S.Genetic ablation of TRPV1 exacerbates pressure overload-induced cardiac hypertrophy［J］.Biomed Pharmacother,2018,99:261-270.
［10］ HURT C M,LU Y,STARY C M,et al.Transient receptor potential vanilloid 1 regulates mitochondrial membrane potential and myocardial reperfusion injury［J］.J Am Heart Assoc,2016,5(9):e003774.
［11］ SUN Z,HAN J,ZHAO W,et al.TRPV1 activation exacerbates hypoxia/reoxygenation-induced apoptosis in H9C2 cells via calcium overload and mitochondrial dysfunction［J］.Int J Mol Sci,2014,15(10):18362-18380.
［12］ ZHONG B,WANG D H.TRPV1 gene knockout impairs pre-conditioning protection against myocardial injury in isolated perfused hearts in mice［J］.Am J Physiol Heart Circ Physiol,2007,293(3):H1791-H1798.
［13］ SHEN-ORR S S,FURMAN D,KIDDB A,et al.Defective sig-naling in the JAK-STAT pathway tracks with chronic inflammation and cardiovascular risk in aging humans［J］.Cell Syst,2016,3(4):374-384.
［14］ DE S,MANNA A,KUNDU S,et al.Allylpyrocatechol attenuates collagen-induced arthritis via attenuation of oxidative stress secondary to modulation of the MAPK,JAK/STAT,and Nrf2/HO-1 Pathways［J］.J Pharmacol Exp Ther,2017,360(2):249-259.
［15］ KIM H C,KIM E,BAE J I,et al.Sevoflurane postconditioning reduces apoptosis by activating the JAK-STAT pathway after transient global cerebral ischemia in rats［J］.J Neurosurg Anesthesiol,2017,29(1):37-45.
［16］ LIU S,YANG Y,SONG Y Q,et al.Protective effects of N(2)L alanyl L glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion［J］.Mol Med Rep,2018,17(4):5102-5108.
［17］ BECKLES D L,MASCARENO E,SIDDIQUI M A Q.Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy［J］.Vascul Pharmacol,2006,45(6):350-357.
［18］ YANG X,GAO X,DU B,et al.Ilex asprella aqueous extracts exert in vivo anti-inflammatory effects by regulating the NF-κB,JAK2/STAT3,and MAPK signaling pathways［J］.J Ethnopharmacol,2018,225:234-243.
［19］ CHEN J,ZHANG W,XU Q,et al.Ang-(1-7) protects HUVECs from high glucose-induced injury and inflammation via inhibition of the JAK2/STAT3 pathway［J］.Int J Mol Med,2018,41(5):2865-2878.
［20］ YU Q,ZENG K W,MA X L,et al.Ginsenoside Rk1 suppresses pro-inflammatory responses in lipopolysaccharide-stimulated RAW264.7 cells by inhibiting the Jak2/Stat3 pathway［J］.Chin J Nat Med,2017,15(10):751-757.
［21］ LI H,MANYI R,BING R,et al.TWEAK/Fn14 mediates atrial-derived HL-1 myocytes hypertrophy via JAK2/STAT3 signalling pathway［J］.J Cell Mol Med,2018,22：4344-4353.
［22］ LINGYAN Y,LIN Q,YONG Y,et al.Heat-shock transcription factor 1 is critically involved in the ischaemia-induced cardiac hypertrophy via JAK2/STAT3 pathway［J］.J Cell Mol Med,2018,22(9):4292-4303.
［23］ PERSOON S,PAULUS M,HIRT S,et al.Cardiac unloading by LVAD support differentially influences components of the cGMP-PKG signaling pathway in ischemic and dilated cardiomyopathy［J］.Heart Vessels,2018,33(8):948-957.
［24］ MATYAS C,NEMETH B T,OLAH A,et al.The soluble guan-ylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus［J］.Cardiovasc Diabetol,2015,14:145.
［25］ SHI Z,FU F,YU L,et al.Vasonatrin peptide attenuates myoc-ardial ischemia/reperfusion injury in diabetic rats and underlying mechanisms［J］.Am J Physiol Heart Circ Physiol,2015,308(4):H281-H290.
［26］ YU L M,DI W C,DONG X,et al.Melatonin protects diabetic he-art against ischemia-reperfusion injury,role of membrane receptor-dependent cGMP-PKG activation［J］.Biochim Biophys Acta Mol Basis Dis,2018,1864(2):563-578.
［27］ WEI Q,ZHU T,XIAO X,et al.Dioscin attenuates myocardial da-mages in diabetic rats maybe by regulating NO-sGC-cGMP-PKG pathway［J］.Ann Clin Lab Sci,2019,49(1):97-104.
［28］ XUE M,LI T,WANG Y，et al.Empagliflozin prevents cardi-omy-opathy via sGC-cGMP-PKG pathway in type 2 diabetes mice［J］.Clin Sci(Lond),2019,133(15):1705-1720.
［29］ PARK M,SANDNER P,KRIEG T.cGMP at the centre of atte-ntion:emerging strategies for activating the cardioprotective PKG pathway［J］.Basic Res Cardiol,2018,113(4):24.
［30］ LEE D I,ZHU G,SASAKI T,et al.Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease［J］.Nature,2015,519(7544):472-476.
［31］ NISHIMURA A,SHIMAUCHI T,TANAKA T,et al.Hypoxia-induced interaction of filamin with Drp1 causes mitochondrial hyperfission-associated myocardial senescence［J］.Sci Signal,2018,11(556):eaat5185.DOI:10.11256/scisignal.aat5185.
［32］ SHIRIHAI O S,SONG M,DORN G W.How mitochondrial dyna-mism orchestrates mitophagy［J］.Circ Res,2015,116(11):1835-1849.
［33］ SUN D,YANG F.Metformin improves cardiac function in mice with heart failure after myocardial infarction by regulating mitochondrial energy metabolism［J］.Biochem Biophys Res Commun,2017,486(2):329-335.
［34］ TSUDA M,FUKUSHIMA A,MATSUMOTO J,et al.Protein acet-ylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure［J］.J Cachexia Sarcopenia Muscle,2018,9(5):844-859.
［35］ CAHILL T J,LEO V,KELLY M,et al.Resistance of dynamin-related protein 1 oligomers to disassembly impairs mitophagy,resulting in myocardial inflammation and heart failure［J］.J Biol Chem,2015,290(43):25907-25919.
［36］ YANG Y,TIAN Y,HU S,et al.Extract of sheng-mai-san amel-iorates myocardial ischemia-induced heart failure by modulating Ca2+-calcineurin-mediated Drp1 signaling pathways［J］.Int J Mol Sci,2017,18(9):1825.
［37］ LUO G,JIAN Z,ZHU Y,et al.Sirt1 promotes autophagy and inhibits apoptosis to protect cardiomyocytes from hypoxic stress［J］.Int J Mol Med,2019,43(5):2033-2043.
［38］ ZHANG H,LIU B,LI T,et al.AMPK activation serves a critical role in mitochondria quality control via modulating mitophagy in the heart under chronic hypoxia［J］.Int J Mol Med,2018,41(1):69-76.
［39］ LIU L,JIN X,HU C F,et al.Exosomes derived from mesenchymal stem cells rescue myocardial ischaemia/reperfusion injury by inducing cardiomyocyte autophagy via AMPK and Akt pathways［J］.Cell Physiol Biochem,2017,43(1):52-68.
［40］ WANG J,SONG Y,LI H,et al.Exacerbated cardiac fibrosis indu-ced by β-adrenergic activation in old mice due to decreased AMPK activity［J］.Clin Exp Pharmacol Physiol,2016,43(11):1029-1037.
［41］ LIU G Z,ZHANG S,LI Y Y,et al.Aldosterone stimulation medi-ates cardiac metabolism remodeling via Sirt1/AMPK signaling in canine model［J］.Naunyn Schmiedebergs Arch Pharmacol,2019,392(7):851-863.
［42］ MENG Z,JING H,GAN L,et al.Resveratrol attenuated estrogen-deficient-induced cardiac dysfunction:role of AMPK,SIRT1,and mitochondrial function［J］.Am J Transl Res,2016,8(6):2641-2649.
相似文献/References:
[1]刘建庄,李金兰,娄清云,等.风湿性心脏病心力衰竭血液流变学改变[J].新乡医学院学报,1992,9(02):108.
[2]苗萍,张喜芳 王延枝.硝酸甘油治疗婴幼儿肺炎心衰疗效观察[J].新乡医学院学报,2000,17(02):129.
[3]任明芬,张三强,张冬红,等.冠心病患者QT间期离散度改变的I临床意义[J].新乡医学院学报,2000,17(03):177.
[4]刘 慧,胡永寸,陈 俭,等.卡维地洛对冠心病心力衰竭患者心室重构和心功能的影响[J].新乡医学院学报,2003,20(01):013.
[5]刘 慧,胡永寸,陈俭。杨庆福.卡维地洛对冠心病心力衰竭患者心室重构和心功能的影响[J].新乡医学院学报,2003,20(01):013.
[6]智佳佳,杜朝政,王 越,等.微RNA和信号通路在骨关节炎病理机制中的作用研究进展[J].新乡医学院学报,2021,38(10):982.[doi:10.7683/xxyxyxb.2021.10.017]
[7]高致炳,韩 冬,张 超.冠状动脉粥样硬化性心脏病并发心力衰竭患者血浆脑利钠肽和高敏C反应蛋白水平变化及临床意义[J].新乡医学院学报,2021,38(9):864.[doi:10.7683/xxyxyxb.2021.09.013]
GAO Zhibing,HAN Dong,ZHANG Chao.Clinical significance of the changes of plasma brain natriuretic peptide and high-sensitivity C-reactive protein levels in patients with coronary atherosclerotic heart disease complicated with heart failure[J].Journal of Xinxiang Medical University,2021,38(10):864.[doi:10.7683/xxyxyxb.2021.09.013]
[8]韩克丽,赵国安,朱 丽,等.微RNA调节心脏重构的病理生理机制研究进展[J].新乡医学院学报,2021,38(12):1200.[doi:10.7683/xxyxyxb.2021.12.019]
[9]韩旭萌,焦明丽,詹合琴.藤黄酸作用靶点及相关信号通路研究进展[J].新乡医学院学报,2020,37(7):696.[doi:10.7683/xxyxyxb.2020.07.023]
[10]余 俊,刘彤鸥,李晓兰.小分子干扰RNA沉默黏着斑激酶基因对人宫颈癌Hela细胞生物学特征的影响[J].新乡医学院学报,2018,35(4):266.[doi:10.7683/xxyxyxb.2018.04.003]
YU Jun,LIU Tong-ou,LI Xiao-lan.Effect of focal adhesion kinase gene silence by small interfering RNA on the biological characteristics of human cervical carcinoma Hela cells[J].Journal of Xinxiang Medical University,2018,35(10):266.[doi:10.7683/xxyxyxb.2018.04.003]